TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway. Xu D, Xu N, Sun L, Yang Z, et al. BMC Cancer 2022;22:1267.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu D, Xu N, Sun L, Yang Z, et al. TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway. BMC Cancer 2022;22:1267.
PMID: 36471278